Zobrazeno 1 - 10 of 65 pro vyhledávání: '"E Benchimol"'
1
Akademický článek
Acute acquired toxoplasmosis: clinical-laboratorial aspects and ophthalmologic evaluation in a cohort of immunocompetent patients
Autor: ES Neves, LN Bicudo, AL Curi, E Carregal, WF Bueno, RG Ferreira, MR Amendoeira, E Benchimol, O Fernandes
Publikováno v: Memorias do Instituto Oswaldo Cruz, Vol 104, Iss 2, Pp 393-396 (2009)
Most cases of acute acquired toxoplasmosis (AAT) are oligosymptomatic and self-limited. Therefore, these infections rarely indicate treatment. Prospective studies of AAT patients are rare in the medical literature. The frequency of systemic manifesta
Externí odkaz: https://doaj.org/article/a8ce396cd03d4457ab5f2deb1665329c
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
A12 EXAMINING THE ASSOCIATIONS BETWEEN PHYSICIAN OR PATIENT GENDER WITH REFERRAL PATTERNS IN GASTROENTEROLOGY FOR NON-SCREENING INDICATIONS
Autor: G Wang, A Boblitz, A Altaf, X Wang, E Benchimol, L Targownik
Publikováno v: Journal of the Canadian Association of Gastroenterology. 6:6-7
Background Gender biases in referral may impact patient care, and may perpetuate gender-based pay inequities. Referral patterns of male and female patients to male and female gastroenterologists (GIs) have not been previously characterized. Purpose W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::06260f21cfd93334d6c7c954b6174ed0
https://doi.org/10.1093/jcag/gwac036.012
Zobrazit plný text záznamu
4
A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
Autor: A Markovinovic, M Herauf, J Quan, L Hracs, J W Windsor, N Sharifi, S Coward, L Caplan, J Gorospe, C Ma, R Panaccione, R Ingram, J Kanji, G Tipples, J Holodinsky, C Berstein, D Mahoney, S Bernatsky, E Benchimol, G G Kaplan
Publikováno v: Journal of the Canadian Association of Gastroenterology. 6:15-16
Background The rapid development and distribution of SARS-CoV-2 vaccines has raised concerns surrounding vaccine safety in immunocompromised populations, such as those with inflammatory bowel disease (IBD). Purpose We described adverse events (AEs) f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::688d8b861c094c14750c1af5cc16b705
https://doi.org/10.1093/jcag/gwac036.170
Zobrazit plný text záznamu
5
A177 RISK OF VENOUS THROMBOEMBOLISM IN COVID-19 PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED MATCHED COHORT STUDY
Autor: R Khan, E Kuenzig, A Tang, J Im, J Widdifield, J McCurdy, G Kaplan, E Benchimol
Publikováno v: Journal of the Canadian Association of Gastroenterology. 6:22-23
Background Venous thromboembolism (VTE), is associated with significant morbidity and mortality. Inflammation increases the risk of VTE, and it is a well-recognised complication of both inflammatory bowel disease (IBD) and COVID-19. Purpose To compar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a4f309456f7ddde9ed1e8376da1fcef
https://doi.org/10.1093/jcag/gwac036.177
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
P503 Early TNF-antagonist maintenance therapy results in better outcomes than immunomodulators in paediatric Crohn’s disease: A multi-centre prospective cohort study
Autor: R Schneider, K Jacobson, H Huynh, D Mack, C Deslandres, J deBruyn, W El-Matary, A Otley, S Lawrence, E Wine, M Sherlock, J Critch, P Jantchou, M Rashid, M Carroll, K Bax, E Seidman, E Benchimol, A Ricciuto, A Wu, E Pullenayegum, T Walters, G Nguyen, A Griffiths, P Church
Publikováno v: Journal of Crohn's and Colitis. 16:i464-i465
Background Early initiation of TNF-antagonist (aTNF) therapy for Crohn’s disease (CD) is associated with greater clinical and endoscopic improvement but trialing an immunomodulator (IM) first remains common in paediatrics. This study aimed to deter
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb75bbabe594723cf0d74e4b49085678
https://doi.org/10.1093/ecco-jcc/jjab232.630
Zobrazit plný text záznamu
10
P590 Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel
Autor: R Hansen, S Meade, F Torrente, J Kammermeier, N M Croft, L de Ridder, D C Wilson, R Klomberg, D Turner, J Martín-de-Carpi, J Bronsky, E Benchimol, J Amil-Dias, D R Mack, G Walker, M Powar, N Burgess, C H van Ommen, P M Irving, M Samaan
Publikováno v: Journal of Crohn's and Colitis. 16:i526-i527
Background Thromboprophylaxis is routinely used in adults with active inflammatory bowel disease (IBD), particularly inpatients, but not in children. Current ECCO/ESPGHAN guidelines support thromboprophylaxis only in children with acute severe coliti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::959309c188adf25cf03dafd089c4c032
https://doi.org/10.1093/ecco-jcc/jjab232.716
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje